Wearable Ambulatory Monitoring Devices Market Share

Wearable Ambulatory Monitoring Devices Market Share Analysis

Cardiovascular diseases (CVD) encompass various conditions like coronary heart diseases, strokes, transient ischemic attacks (TIA), peripheral arterial diseases, and aortic diseases. Several factors contribute to the onset of these diseases, including smoking, high cholesterol levels, elevated blood pressure, tobacco use, physical inactivity, unhealthy dietary habits, excessive alcohol consumption, and conditions like overweight and obesity.

According to data from the Centers for Disease Control and Prevention (CDC) in 2017, over 18.2 million American adults aged 20 and above were affected by coronary heart disease. Additionally, approximately 805,000 Americans experienced a heart attack in the same year. Furthermore, as per statistics shared by the American College of Cardiology Foundation in 2019, it was projected that approximately 1 million coronary heart disease events would occur in the US, involving 335,000 recurrent and 720,000 new coronary cases.

A parallel trend of increased heart disease incidence has been observed globally. In the UK, for instance, the British Heart Foundation reported that by December 2019, around 1.4 million individuals were diagnosed with Atrial Fibrillation, and a concerning one in six patients didn't receive effective treatment. This demand for disease monitoring is anticipated to propel the need for wearable ambulatory monitoring devices.

Given the escalating prevalence of chronic cardiovascular ailments, continuous monitoring of patients with heart conditions is paramount. In this context, cardiac monitoring devices play a pivotal role in overseeing patients' health and mitigating the risks associated with heart failure and its related complications. Each year, more than 795,000 Americans experience a new or recurrent stroke. A substantial majority, approximately 90%, develop a stroke due to modifiable risk factors, with 74% attributed to behavioral factors. Wearable ambulatory monitoring devices can play a critical role in identifying these risk factors earlier by tracking physiological changes, enabling the early detection of CVDs.

Consequently, the burgeoning prevalence of cardiac diseases is anticipated to drive the demand and utilization of ambulatory monitoring devices. This trend is poised to create a conducive environment for the market's growth throughout the forecast period.